Clinical Trials in Fribourg, Switzerland
Locations / Fribourg, Switzerland
Delta Trials hosts 220 clinical trials conducted in Fribourg, Switzerland, making it a notable site of clinical research activity. These trials covering 281 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 19 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Fribourg.
220
Total Trials
281
Conditions
19
Terminated since 2020
Browse by condition (281 total)
- Coronary artery disease 17 trialsAll Coronary artery disease trials
- Rheumatoid arthritis 12 trialsAll Rheumatoid arthritis trials
- Non-small cell lung cancer 9 trialsAll Non-small cell lung cancer trials
- Breast cancer 8 trialsAll Breast cancer trials
- Atrial fibrillation 5 trialsAll Atrial fibrillation trials
- Prostate cancer 5 trialsAll Prostate cancer trials
- Peripheral arterial disease 4 trialsAll Peripheral arterial disease trials
- Acute coronary syndrome 4 trialsAll Acute coronary syndrome trials
- Nsclc 4 trialsAll Nsclc trials
- Acute myeloid leukemia 3 trialsAll Acute myeloid leukemia trials
- Pulmonary embolism 3 trialsAll Pulmonary embolism trials
- Psoriatic arthritis 3 trialsAll Psoriatic arthritis trials
- Venous thromboembolism 3 trialsAll Venous thromboembolism trials
- Lung cancer 3 trialsAll Lung cancer trials
- Hypertension 2 trialsAll Hypertension trials
- Prostatic neoplasms 2 trialsAll Prostatic neoplasms trials
- All Myelodysplastic syndrome with excess blasts-2 trials
- All Nsclc (advanced non-small cell lung cancer) trials
- Metastatic colorectal cancer 2 trialsAll Metastatic colorectal cancer trials
- Cardiac arrhythmias 2 trialsAll Cardiac arrhythmias trials